NASDAQ:CSBR
Champions Oncology, Inc.
- Stock
Last Close
4.70
17/05 20:00
Market Cap
85.03M
Beta: 0.87
Volume Today
2.73K
Avg: 10.77K
PE Ratio
−8.40
PFCF: −16.74
Apr '14 | Apr '15 | Apr '16 | Apr '17 | Apr '18 | Apr '19 | Apr '20 | Apr '21 | Apr '22 | Apr '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 1.09M - | 1.20M 9.61% | 1.66M 38.20% | 1.87M 13.23% | 2.00M 6.88% | 2.48M 23.84% | 2.97M 19.88% | 2.52M 15.35% | 2.38M 5.40% | 4.10M 72.24% | |
average receivables | 911K - | 1.19M 30.90% | 1.19M 0.55% | 1.79M 51.18% | 3.10M 72.64% | 4.15M 33.97% | 4.57M 10.28% | 5.88M 28.52% | 8.25M 40.35% | 8.76M 6.21% | |
book value per share | 0.57 - | 0.93 62.53% | 0.03 97.05% | 0.04 33.22% | -0.00 106.24% | 0.20 8,786.01% | 0.45 127.53% | 0.57 25.90% | 0.69 21.92% | 0.34 50.33% | |
capex per share | -0.04 - | -0.01 67.21% | -0.04 170.50% | -0.07 88.56% | -0.11 60.14% | -0.07 34.16% | -0.19 154.88% | -0.25 33.22% | -0.18 27.66% | -0.21 17.41% | |
capex to depreciation | -1.10 - | -0.56 49.38% | -2.06 271.19% | -4.56 120.90% | -3.41 25.13% | -1.38 59.69% | -2.69 95.53% | -2.77 2.98% | -1.47 47.12% | -1.28 12.73% | |
capex to operating cash flow | 0.07 - | 0.01 81.87% | 0.05 303.87% | 0.27 440.44% | 1.00 271.66% | -0.45 144.68% | -0.76 70.62% | 1.95 355.41% | -0.37 118.80% | -0.73 97.90% | |
capex to revenue | -0.02 - | -0.01 33.73% | -0.03 114.47% | -0.05 72.61% | -0.06 22.16% | -0.03 49.25% | -0.07 124.29% | -0.08 15.68% | -0.05 39.28% | -0.05 9.82% | |
cash per share | 1.05 - | 1.08 2.41% | 0.30 72.38% | 0.30 1.03% | 0.08 74.07% | 0.29 266.92% | 0.70 146.76% | 0.36 49.35% | 0.68 91.32% | 0.75 9.48% | |
days of inventory on hand | |||||||||||
days payables outstanding | 57.17 - | 67.62 18.27% | 79.67 17.83% | 69.67 12.56% | 74.50 6.94% | 71.82 3.59% | 67.89 5.48% | 32.19 52.58% | 44.30 37.60% | 65.93 48.83% | |
days sales outstanding | 41.87 - | 43.65 4.25% | 42.83 1.90% | 53.86 25.76% | 70.63 31.15% | 59.02 16.44% | 54.20 8.17% | 62.13 14.64% | 70.70 13.80% | 54.28 23.23% | |
debt to assets | 0.00 - | 0.00 60.44% | 0.18 12,786.27% | 0.35 90.12% | 0.27 23.11% | 0.25 6.33% | |||||
debt to equity | -1.16 - | 0.01 100.62% | 0.71 9,889.57% | 1.29 80.98% | 1.04 19.49% | 1.85 78.23% | |||||
dividend yield | |||||||||||
earnings yield | -0.12 - | -0.21 70.65% | -0.31 51.10% | -0.24 23.53% | -0.03 86.76% | 0.00 103.94% | -0.02 1,837.67% | 0.00 110.97% | 0.01 128.22% | -0.08 1,599.31% | |
enterprise value | 55.38M - | 54.34M 1.87% | 30.93M 43.09% | 25.59M 17.27% | 46.89M 83.24% | 99.75M 112.74% | 86.89M 12.89% | 145.90M 67.91% | 101.81M 30.21% | 64.29M 36.85% | |
enterprise value over ebitda | -9.16 - | -4.17 54.44% | -3.04 27.04% | -3.85 26.57% | -47.17 1,124.23% | 113.87 341.40% | -282.10 347.75% | 95.86 133.98% | 45.57 52.46% | -46.06 201.05% | |
ev to operating cash flow | -16.13 - | -5.64 65.02% | -4.79 15.05% | -9.01 87.95% | -38.24 324.47% | 53.57 240.07% | 29.91 44.17% | -86.79 390.18% | 15.67 118.06% | 16.26 3.74% | |
ev to sales | 4.79 - | 6.13 27.88% | 2.77 54.89% | 1.66 39.97% | 2.32 39.51% | 3.69 59.09% | 2.70 26.60% | 3.55 31.43% | 2.07 41.68% | 1.19 42.43% | |
free cash flow per share | -0.65 - | -1.12 71.41% | -0.78 30.54% | -0.33 57.81% | -0.22 32.05% | 0.09 140.63% | 0.06 36.20% | -0.38 752.95% | 0.31 182.52% | 0.08 74.34% | |
free cash flow yield | -0.06 - | -0.15 155.71% | -0.20 32.07% | -0.12 38.23% | -0.05 58.78% | 0.01 119.40% | 0.01 24.96% | -0.04 569.79% | 0.04 215.30% | 0.02 59.45% | |
graham net net | 0.22 - | 0.71 227.16% | -0.23 131.95% | -0.24 5.03% | -0.39 64.76% | -0.22 43.55% | -0.30 34.18% | -0.78 162.62% | -0.77 1.38% | -1.00 30.22% | |
graham number | 4.11 - | 5.61 36.35% | 0.86 84.68% | 0.72 16.58% | 0.08 88.33% | 0.22 167.73% | 1.30 479.78% | 0.57 56.19% | 0.80 41.12% | 1.74 117.09% | |
income quality | 0.46 - | 0.73 58.10% | 0.62 15.72% | 0.41 33.21% | 0.81 97.46% | 14.55 1,685.73% | -1.47 110.11% | -5.03 242.17% | 11.86 335.57% | -0.74 106.25% | |
intangibles to total assets | 0.08 - | 0.06 26.40% | 0.12 108.53% | 0.08 27.89% | 0.08 0.83% | 0.06 28.29% | 0.02 72.82% | 0.01 24.79% | 0.01 22.01% | 0.01 3.11% | |
interest coverage | 6.92 - | 25.29 - | |||||||||
interest debt per share | 0.00 - | 0.00 84.02% | 0.32 6,512.01% | 0.73 127.87% | 0.72 1.59% | 0.64 11.69% | |||||
inventory turnover | |||||||||||
invested capital | -1.16 - | 0.01 100.62% | 0.71 9,889.57% | 1.29 80.98% | 1.04 19.49% | 1.85 78.23% | |||||
market cap | 61.27M - | 63.70M 3.97% | 33.51M 47.39% | 28.88M 13.82% | 47.70M 65.15% | 102.97M 115.86% | 91.43M 11.20% | 140.98M 54.19% | 101.35M 28.11% | 65.81M 35.07% | |
net current asset value | 1.93M - | 6.78M 251.22% | -1.20M 117.70% | -1.74M 45.29% | -3.04M 74.68% | -1.10M 63.69% | -1.94M 75.20% | -7.53M 289.10% | -6.62M 12.15% | -10.22M 54.40% | |
net debt to ebitda | 0.97 - | 0.72 26.25% | 0.25 64.59% | 0.50 95.01% | 0.82 65.05% | -3.68 549.00% | 14.75 501.24% | 3.23 78.12% | 0.21 93.64% | 1.09 429.59% | |
net income per share | -1.32 - | -1.51 14.39% | -1.20 20.53% | -0.63 47.76% | -0.14 78.18% | 0.01 108.25% | -0.17 1,577.40% | 0.03 115.24% | 0.04 63.35% | -0.39 1,048.78% | |
operating cash flow per share | -0.61 - | -1.11 80.86% | -0.74 33.02% | -0.26 65.11% | -0.11 56.91% | 0.16 247.36% | 0.25 49.39% | -0.13 152.16% | 0.49 484.79% | 0.29 40.67% | |
payables turnover | 6.38 - | 5.40 15.45% | 4.58 15.13% | 5.24 14.36% | 4.90 6.49% | 5.08 3.73% | 5.38 5.79% | 11.34 110.88% | 8.24 27.32% | 5.54 32.81% | |
receivables turnover | 8.72 - | 8.36 4.08% | 8.52 1.93% | 6.78 20.48% | 5.17 23.75% | 6.18 19.67% | 6.73 8.90% | 5.87 12.77% | 5.16 12.13% | 6.72 30.26% | |
research and ddevelopement to revenue | 0.20 - | 0.55 178.76% | 0.38 31.39% | 0.28 25.73% | 0.22 21.95% | 0.18 18.47% | 0.18 2.79% | 0.18 3.77% | 0.19 8.86% | 0.21 12.28% | |
return on tangible assets | -0.90 - | -1.15 27.84% | -2.05 77.08% | -0.94 54.15% | -0.20 78.34% | 0.01 105.95% | -0.10 900.81% | 0.01 112.67% | 0.02 27.61% | -0.16 1,104.11% | |
revenue per share | 2.06 - | 1.02 50.53% | 1.28 26.12% | 1.40 9.24% | 1.84 31.09% | 2.39 29.75% | 2.71 13.64% | 3.12 15.16% | 3.72 19.13% | 3.98 6.91% | |
roe | -2.32 - | -1.63 29.62% | -43.89 2,591.90% | -17.21 60.79% | 60.20 449.80% | 0.06 99.90% | -0.37 749.34% | 0.04 112.11% | 0.06 33.98% | -1.15 2,010.12% | |
roic | -1.96 - | -1.66 15.49% | -43.73 2,536.44% | -17.07 60.97% | -353.29 1,969.69% | 0.07 100.02% | -0.12 284.63% | 0.01 108.52% | 0.02 96.40% | -0.21 1,113.89% | |
sales general and administrative to revenue | 0.53 - | 0.60 13.58% | 0.46 23.22% | 0.32 30.39% | 0.20 37.55% | 0.17 14.07% | 0.21 19.13% | 0.16 22.93% | 0.19 17.00% | 0.19 2.39% | |
shareholders equity per share | 0.57 - | 0.93 62.53% | 0.03 97.05% | 0.04 33.22% | -0.00 106.24% | 0.20 8,786.01% | 0.45 127.53% | 0.57 25.90% | 0.69 21.92% | 0.34 50.33% | |
stock based compensation to revenue | 0.24 - | 0.36 46.80% | 0.23 34.85% | 0.17 25.68% | 0.05 71.28% | 0.02 52.63% | 0.02 20.51% | 0.01 21.99% | 0.02 27.45% | 0.02 13.64% | |
tangible asset value | 2.53M - | 7.39M 192.33% | -431K 105.83% | -269K 37.59% | -694K 157.99% | 1.57M 326.08% | 4.98M 217.59% | 7.09M 42.34% | 8.76M 23.52% | 4.30M 50.91% | |
tangible book value per share | 0.45 - | 0.85 88.47% | -0.05 105.83% | -0.02 50.53% | -0.06 157.50% | 0.14 319.36% | 0.42 204.10% | 0.54 28.31% | 0.66 22.97% | 0.32 52.16% | |
working capital | 3.94M - | 6.97M 76.83% | -966K 113.87% | -1.58M 63.35% | -2.42M 53.49% | -103K 95.75% | 1.41M 1,470.87% | 1.43M 1.35% | 2.19M 52.69% | -2.28M 204.16% |
All numbers in USD (except ratios and percentages)